AU2880192A - 2-aminopropan-1,3-diol chemotherapeutic agents - Google Patents

2-aminopropan-1,3-diol chemotherapeutic agents

Info

Publication number
AU2880192A
AU2880192A AU28801/92A AU2880192A AU2880192A AU 2880192 A AU2880192 A AU 2880192A AU 28801/92 A AU28801/92 A AU 28801/92A AU 2880192 A AU2880192 A AU 2880192A AU 2880192 A AU2880192 A AU 2880192A
Authority
AU
Australia
Prior art keywords
agent
tumor
potentiating
cell
growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28801/92A
Other languages
English (en)
Inventor
Jack B Jiang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Sphinx Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sphinx Pharmaceuticals Corp filed Critical Sphinx Pharmaceuticals Corp
Publication of AU2880192A publication Critical patent/AU2880192A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU28801/92A 1991-10-21 1992-10-19 2-aminopropan-1,3-diol chemotherapeutic agents Abandoned AU2880192A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78073291A 1991-10-21 1991-10-21
US780732 1991-10-21

Publications (1)

Publication Number Publication Date
AU2880192A true AU2880192A (en) 1993-05-21

Family

ID=25120504

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28801/92A Abandoned AU2880192A (en) 1991-10-21 1992-10-19 2-aminopropan-1,3-diol chemotherapeutic agents

Country Status (5)

Country Link
EP (1) EP0609356A4 (xx)
JP (1) JPH07501521A (xx)
AU (1) AU2880192A (xx)
CA (1) CA2120234A1 (xx)
WO (1) WO1993008120A1 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7030219B2 (en) 2000-04-28 2006-04-18 Johns Hopkins University B7-DC, Dendritic cell co-stimulatory molecules
PE20110435A1 (es) * 2008-08-25 2011-07-20 Amplimmune Inc Composiciones antagonistas del pd-1

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1237670A (en) * 1983-05-26 1988-06-07 Andrew S. Janoff Drug preparations of reduced toxicity
US4816450A (en) * 1986-09-15 1989-03-28 Duke University Inhibition of protein kinase C by long-chain bases

Also Published As

Publication number Publication date
EP0609356A1 (en) 1994-08-10
EP0609356A4 (en) 1994-10-26
CA2120234A1 (en) 1993-04-29
WO1993008120A1 (en) 1993-04-29
JPH07501521A (ja) 1995-02-16

Similar Documents

Publication Publication Date Title
AU750521B2 (en) Formulations and methods for reducing toxicity of antineoplastic agents
RU2214238C2 (ru) Фармацевтическая композиция, обладающая противоопухолевым действием со сниженными побочными эффектами, содержащая противоопухолевый агент и производное гидроксамовой кислоты
CA1306693C (en) Pharmaceutical compositions having antineoplastic activity
WO1995019769A1 (en) Combinations of a creatine compound with a hyperplastic inhibitory agent for inhibiting undesirable cell growth
CZ289629B6 (cs) 2,4-Disulfonyl-alfa-fenyl-terc.butylnitron, jeho soli, farmaceutická kompozice s jeho obsahem a pouľití
JP2009263371A (ja) 抗癌組み合わせ
CZ288063B6 (cs) Farmaceutický prostředek pro léčení rakovin
CN109498627B (zh) 一种治疗肿瘤的药物组合物及其应用
US6063780A (en) Method of treating a tumor
AU2009215329B2 (en) Combination comprising paclitaxel for treating ovarian cancer
US5049396A (en) Pharmaceutical compositions with anti-cancer activity and method for the treatment of cancer sensitive to treatment
JP2009536956A (ja) 抗癌治療法
EP1503748B1 (en) 2,2'-Dithio-bis(ethanesulfonate) for use in inhibiting paclitaxel-induced abnormal thermoesthesia
AU2880192A (en) 2-aminopropan-1,3-diol chemotherapeutic agents
US20130101680A1 (en) Radiotherapy enhancer
EP1206256A2 (en) Combination therapy using pentafluorobenzenesulfonamide and platin compound
RU2657604C2 (ru) Противоопухолевый агент, включающий гидрат гидрохлорида иринотекана
WO2020218562A1 (ja) 治療抵抗性がんの予防又は治療用の医薬組成物
WO2000056334A1 (en) Use of imino sugars for anti-tumor therapy
JPH04338328A (ja) 血管形成阻害剤として有用なベンゾイルカルビノール及びそのエステル
EP3127544B1 (en) Anti-tumor drug containing anti-tumor platinum complex, and anti-tumor effect enhancer
KR100457113B1 (ko) 세라마이드류 또는 그 유도체와 다이메틸스핑고신을 유효성분으로 포함하는 방사선민감도 증진제
US20060025484A1 (en) Use of 1-(2-chloroethyl)-1-nitroso-3-(2-hydroxyethyl)urea for treatment of pancreatic carcinomas, soft tissue sarcomas, testicular tumors, lymphomas, thymomas, wilms' tumors, renal carcinomas, melanomas, lung tumors, intracerebral metastases, tumors in the head and neck area and mammary carcinomas
US4006235A (en) Treating CNS lymphoma
US4005203A (en) Treatment of meningeal leukemia with diamino dichlorophenyl pyrimidine